Salas-Alanís Julio C, Scott Claire A, Fajardo-Ramírez Oscar R, Duran Carola, Moreno-Treviño María G, Kelsell David P
Departamento de Ciencias Básicas, Universidad de Monterrey, Aguascalientes, Mexico.
Centre for Cell Biology and Cutaneous Research, The Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Mol Syndromol. 2016 Jul;7(3):160-3. doi: 10.1159/000446619. Epub 2016 Jun 2.
GAPO syndrome is a very rare genetic disorder characterized by growth retardation, alopecia, pseudoanodontia and progressive optic atrophy (GAPO). To date, only 30 cases have been described worldwide. Recently, gene alterations in the ANTXR1 gene have been reported to be causative of this disorder, and an autosomal recessive pattern has been observed. This gene encodes a matrix-interacting protein that works as an adhesion molecule. In this report, we describe 2 homozygous siblings diagnosed with GAPO syndrome carrying a new missense mutation. This mutation produces the substitution of a glutamine in position 137 for a leucine (c.410A>T, p.Q137L).
GAPO综合征是一种非常罕见的遗传性疾病,其特征为生长发育迟缓、脱发、假性无牙症和进行性视神经萎缩(GAPO)。迄今为止,全球仅报道了30例病例。最近,有报道称ANTXR1基因的改变是导致该疾病的原因,并且观察到其呈现常染色体隐性遗传模式。该基因编码一种作为粘附分子起作用的基质相互作用蛋白。在本报告中,我们描述了2名患有GAPO综合征的纯合子同胞,他们携带一种新的错义突变。这种突变导致第137位的谷氨酰胺被亮氨酸取代(c.410A>T,p.Q137L)。